Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adjuvant Therapy
8%
Adverse Event
8%
Antidiabetic Activity
13%
Antidiabetic Agent
11%
Apelin
8%
Beta Cell
95%
Blood Glucose
8%
Body Weight
13%
Cafeteria
7%
Cell Dedifferentiation
9%
Cell Differentiation
7%
Cell Lineage
22%
Cell Proliferation
22%
Cell Survival
9%
Cell Transdifferentiation
100%
Cholecystokinin
18%
Dapagliflozin
10%
Diabetes
70%
Diabetes Mellitus
22%
Diabetic Obesity
18%
Drug Therapy
8%
Endocrine Cell
6%
Exenatide
19%
Food Intake
11%
Gastric Inhibitory Polypeptide
10%
Gastrin
8%
Glucagon
33%
Glucagon Like Peptide 1
24%
Glucagon Like Peptide 1 Receptor
15%
Glucagon Receptor Antagonist
8%
Glucagon-Like Peptide-1 Agonist
8%
Gut
14%
Hydrocortisone
20%
Incretin
14%
Insulin Dependent Diabetes Mellitus
8%
Insulin Resistance
12%
Liraglutide
10%
Low Drug Dose
8%
Metabolic Stress
7%
Ob/Ob Mouse
8%
Oxyntomodulin
8%
Pancreas Polypeptide
17%
Pancreatic Islet
57%
Programmed Cell Death
26%
Receptor
21%
Sitagliptin
10%
Streptozocin
62%
Transgenic Mouse
10%
Vasopressin V1a Receptor
8%
Vasopressin V1b Receptor
8%
Biochemistry, Genetics and Molecular Biology
Agonist
11%
Antidiabetic Activity
5%
Blood Plasma
6%
Body Weight
6%
Cell Dedifferentiation
5%
Cell Function
8%
Cell Growth
14%
Cell Lineage
20%
Cell Plasticity
9%
Cell Proliferation
10%
Cell Survival
11%
Cellular Differentiation
5%
Cholecystokinin
9%
Cholecystokinin Receptor
8%
Drug Therapy
8%
Enteroglucagon
8%
Gastric Inhibitory Polypeptide
10%
Glucagon
27%
Glucagon Receptor
8%
Glucagon-Like Peptide 1 Receptor
8%
Glucagon-Like Peptide-1
11%
Glucose Blood Level
6%
Grand Unified Theory
11%
Incretin
8%
Insulin Release
7%
Liraglutide
10%
Low Drug Dose
8%
Morphology
5%
Neuropeptide
24%
Ob/Ob Mouse
8%
Pancreatic Polypeptide
26%
Peptide YY
18%
Peptidergic
8%
Petromyzon
20%
Programmed Cell Death
17%
Receptor Agonists
8%
Receptor Antagonist
8%
Streptozotocin
35%
Transdifferentiation
45%
Pharmacology, Toxicology and Pharmaceutical Science
Antidiabetic Agent
8%
Apelin
8%
Carboxamide
5%
Cholecystokinin
8%
Cholecystokinin Receptor
8%
Combination Therapy
6%
Dapagliflozin
10%
Diabetes Mellitus
21%
Diabetic Obesity
18%
Diabetogenesis
8%
Exendin 4
27%
Gastric Inhibitory Polypeptide
10%
Gastrin
8%
Glucagon
34%
Glucagon Like Peptide 1 Receptor Agonist
8%
Glucagon Receptor Antagonist
8%
Glucagon-Like Peptide 1 Receptor
15%
Glucagon-Like Peptide-1
24%
Hydrocortisone
5%
Incretin
13%
Insulin Dependent Diabetes Mellitus
8%
Insulin Resistance
8%
Liraglutide
10%
Mouse Model
11%
Neuropeptide
8%
Neuropeptide Y1 Receptor
12%
Ob/Ob Mouse
8%
Oxyntomodulin
8%
Pancreas Islet Cell Hyperplasia
8%
Pancreas Polypeptide
17%
Peptide YY
9%
Petromyzon
14%
Pharmacotherapy
8%
Receptor
19%
Receptor Agonist
8%
Sodium Glucose Cotransporter
5%
Streptozotocin
44%
Tarantula
17%